CHPA Applauds Continued House Efforts to Advance Monograph Reform

WASHINGTON, D.C. (June 24, 2019) — The Consumer Healthcare Products Association (CHPA) released the following statement upon the introduction of the Over-the-Counter Monograph Safety, Innovation, and Reform Act, bipartisan legislation to modernize the regulatory system overseeing the vast majority of over-the-counter (OTC) medicines – called the OTC Monograph system. The legislation is sponsored by House Energy and Commerce Committee members, including Representatives Diana DeGette (D-Colo.), Bob Latta (R-Ohio), Debbie Dingell (D-Mich.), and Brett Guthrie (R-Ky).

“The drumbeat around OTC Monograph reform has not slowed since it was first introduced in 2017,” said CHPA President and CEO, Scott Melville. “Democratic and Republican lawmakers in both the House and Senate recognize the importance of making commonsense regulatory reforms to modernize the system that oversees the majority of OTC medicines. Doing so would increase the efficiency and responsiveness necessary to protect consumer health and spur innovation. The House has already passed OTC Monograph reform three times and Representatives DeGette, Latta, Dingell, and Guthrie continue demonstrating their steadfast commitment to seeing the legislation over the finish line. CHPA shares their commitment and applauds them for their tireless efforts. We look forward to seeing the bill advance.”


The Consumer Healthcare Products Association (CHPA) is the 138-year-old national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system more than $7, contributing a total of $146 billion in savings each year. CHPA is committed to empowering self-care by preserving and expanding choice and availability of consumer healthcare products. 


Contact: Lauren Bloomberg (